Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted contrast agents for MRI of amyloid deposition

Targeted contrast agents for MRI of amyloid deposition

US Patent 11116854 · Granted Sep 14, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting ligands for tau pathology2025
Dual mode gadolinium nanoparticle contrast agents2024
Targeted contrast agents for MRI of alpha-synuclein deposition2023
Targeted contrast agents for MRI of alpha-synuclein deposition2023
Targeting ligands for tau pathology2023
Targeting nanoparticles2022
Targeting nanoparticles2022
Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR si2022
Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR si2022
MRI imaging of amyloid plaque using liposomes2021
MRI imaging of amyloid plaque using liposomes2021
Liposomal gadolinium (GD) contrast agent “NMRX” for T1-MRI2021